FDA approves Biotest’s plasma-derived treatment for immunodeficiencies
Biotest, a subsidiary of Grifols, has received FDA approval for Yimmugo, a treatment for primary antibody deficiency syndromes (PID)
Archives for June 20, 2024
Roche and Ascidian Therapeutics partner to develop RNA editing therapeutics
With Roche as a partner, Ascidian Therapeutics aims to treat conditions that currently cannot be addressed by existing gene editing technology
Mainz Biomed CEO discusses stool test for colorectal cancer vs Galleri blood test
Catching cancer early can save lives because it can be treated before it spreads in the body.